Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Could the same medication that causes people to lose weight hold the key to reducing drinking? In a new paper at the European ...

Pharma major Biocon says its businesses are at a promising inflection point, with strong momentum expected to continue.

PEOPLE regain the weight they lose on fat jabs within two years of stopping the drugs, research suggests. Ozempic-style ...

Improvements with GLP-1 RAs in psoriasis and other chronic skin diseases point to their increased use in dermatology and a ...

The biosimilars business accounted for 58% of Biocon's overall revenue in FY25. Biocon Biologics had said it would likely ...

Medications like semaglutide and liraglutide may help to reduce the risk of heart attacks, strokes, and other major adverse ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...

The drugs help severely obese children to lose weight on top of the diet and lifestyle plan they are already following.